Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 Feb;68(2):137–143. doi: 10.1136/jnnp.68.2.137

Neurocysticercosis and epilepsy in developing countries

D Pal 1, A Carpio 1, J Sander 1
PMCID: PMC1736787  PMID: 10644776

Abstract

Neurocysticercosis is a disease of poverty and underdevelopment. Little is known about the natural history of the infection in humans, but some of the mechanisms whereby the parasite remains silent and evades the host immune response are understood. Symptomatic neurocysticercosis usually results from host inflammatory response after parasite death, and the clinical manifestations can be diverse. There is no evidence that cysticidal treatment does more good than harm in addition to conventional antiepileptic treatment. Population control measures involving immunisation or mass treatment have not shown long term effectiveness.
Epilepsy, similarly to neurocysticercosis, is a largely unrecognised but increasing burden on the welfare and economies of developing countries. The technology of drug treatment and psychosocial rehabilitation is well known but requires widespread and effective dissemination at low cost. There is little epidemiological data on risk factors for epilepsy in developing countries on which to base prevention strategies. The public health prioritisation of chronic disorders such as epilepsy remains a challenge for policy and practice in developing countries.
For both neurocysticercosis and epilepsy, there is a dilemma about whether limited public resources would better be spent on general economic development, which would be expected to have a broad impact on the health and welfare of communities, or on specific programmes to help individual affected people with neurocysticercosis and epilepsy. Either approach requires detailed economic evaluation.



Full Text

The Full Text of this article is available as a PDF (173.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almarri A., Batchelor J. R. HLA and hepatitis B infection. Lancet. 1994 Oct 29;344(8931):1194–1195. doi: 10.1016/s0140-6736(94)90510-x. [DOI] [PubMed] [Google Scholar]
  2. Austin J. K., McDermott N. Parental attitude and coping behaviors in families of children with epilepsy. J Neurosci Nurs. 1988 Jun;20(3):174–179. doi: 10.1097/01376517-198806000-00008. [DOI] [PubMed] [Google Scholar]
  3. Aziz H., Ali S. M., Frances P., Khan M. I., Hasan K. Z. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia. 1994 Sep-Oct;35(5):950–958. doi: 10.1111/j.1528-1157.1994.tb02539.x. [DOI] [PubMed] [Google Scholar]
  4. Baranwal A. K., Singhi P. D., Khandelwal N., Singhi S. C. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J. 1998 Aug;17(8):696–700. doi: 10.1097/00006454-199808000-00007. [DOI] [PubMed] [Google Scholar]
  5. Cao W., van der Ploeg C. P., Xu J., Gao C., Ge L., Habbema J. D. Risk factors for human cysticercosis morbidity: a population-based case-control study. Epidemiol Infect. 1997 Oct;119(2):231–235. doi: 10.1017/s0950268897007619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carpio A. Diagnostic criteria for human cysticercosis. J Neurol Sci. 1998 Dec 11;161(2):185–188. doi: 10.1016/s0022-510x(98)00227-5. [DOI] [PubMed] [Google Scholar]
  7. Carpio A., Escobar A., Hauser W. A. Cysticercosis and epilepsy: a critical review. Epilepsia. 1998 Oct;39(10):1025–1040. doi: 10.1111/j.1528-1157.1998.tb01287.x. [DOI] [PubMed] [Google Scholar]
  8. Craig P. S., Rogan M. T., Allan J. C. Detection, screening and community epidemiology of taeniid cestode zoonoses: cystic echinococcosis, alveolar echinococcosis and neurocysticercosis. Adv Parasitol. 1996;38:169–250. doi: 10.1016/s0065-308x(08)60035-4. [DOI] [PubMed] [Google Scholar]
  9. Del Brutto O. H. Neurocysticercosis. Curr Opin Neurol. 1997 Jun;10(3):268–272. doi: 10.1097/00019052-199706000-00017. [DOI] [PubMed] [Google Scholar]
  10. Del Brutto O. H., Santibañez R., Noboa C. A., Aguirre R., Díaz E., Alarcón T. A. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992 Feb;42(2):389–392. doi: 10.1212/wnl.42.2.389. [DOI] [PubMed] [Google Scholar]
  11. Del Brutto O. H., Wadia N. H., Dumas M., Cruz M., Tsang V. C., Schantz P. M. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996 Oct;142(1-2):1–6. doi: 10.1016/0022-510x(96)00130-x. [DOI] [PubMed] [Google Scholar]
  12. Dumas M., Grunitzky E., Deniau M., Dabis F., Bouteille B., Belo M., Pestre-Alexandre M., Catanzano G., Darde M. L., D'Almeida M. Epidemiological study of neuro-cysticercosis in northern Togo (West Africa). Acta Leiden. 1989;57(2):191–196. [PubMed] [Google Scholar]
  13. Evans C. A., Garcia H. H., Hartnell A., Gilman R. H., Jose P. J., Martinez M., Remick D. G., Williams T. J., Friedland J. S. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun. 1998 Sep;66(9):4522–4525. doi: 10.1128/iai.66.9.4522-4525.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Evans C. A., Gonzalez A. E., Gilman R. H., Verastegui M., Garcia H. H., Chavera A., Pilcher J. B., Tsang V. C. Immunotherapy for porcine cysticercosis: implications for prevention of human disease. Cysticercosis Working Group in Peru. Am J Trop Med Hyg. 1997 Jan;56(1):33–37. doi: 10.4269/ajtmh.1997.56.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fernandez-Reyes D., Craig A. G., Kyes S. A., Peshu N., Snow R. W., Berendt A. R., Marsh K., Newbold C. I. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet. 1997 Aug;6(8):1357–1360. doi: 10.1093/hmg/6.8.1357. [DOI] [PubMed] [Google Scholar]
  16. Flisser A., Madrazo I., Plancarte A., Schantz P., Allan J., Craig P., Sarti E. Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet. 1993 Sep 18;342(8873):748–748. doi: 10.1016/0140-6736(93)91743-6. [DOI] [PubMed] [Google Scholar]
  17. Garcia-Noval J., Allan J. C., Fletes C., Moreno E., DeMata F., Torres-Alvarez R., Soto de Alfaro H., Yurrita P., Higueros-Morales H., Mencos F. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg. 1996 Sep;55(3):282–289. doi: 10.4269/ajtmh.1996.55.282. [DOI] [PubMed] [Google Scholar]
  18. Garcia H. H., Gilman R., Martinez M., Tsang V. C., Pilcher J. B., Herrera G., Diaz F., Alvarado M., Miranda E. Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG) Lancet. 1993 Jan 23;341(8839):197–200. doi: 10.1016/0140-6736(93)90064-n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Garcia H. H., Harrison L. J., Parkhouse R. M., Montenegro T., Martinez S. M., Tsang V. C., Gilman R. H. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):411–414. doi: 10.1016/s0035-9203(98)91069-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goodman K. A., Ballagh S. A., Carpio A. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. Am J Trop Med Hyg. 1999 Jan;60(1):70–74. doi: 10.4269/ajtmh.1999.60.70. [DOI] [PubMed] [Google Scholar]
  21. Hackett R. J., Hackett L., Bhakta P. The prevalence and associated factors of epilepsy in children in Calicut District, Kerala, India. Acta Paediatr. 1997 Nov;86(11):1257–1260. doi: 10.1111/j.1651-2227.1997.tb14857.x. [DOI] [PubMed] [Google Scholar]
  22. Hill A. V. Genetics of infectious disease resistance. Curr Opin Genet Dev. 1996 Jun;6(3):348–353. doi: 10.1016/s0959-437x(96)80013-x. [DOI] [PubMed] [Google Scholar]
  23. Kaiser C., Kipp W., Asaba G., Mugisa C., Kabagambe G., Rating D., Leichsenring M. The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus. Bull World Health Organ. 1996;74(4):361–367. [PMC free article] [PubMed] [Google Scholar]
  24. Kalra V., Sethi A. Childhood neurocysticercosis--epidemiology, diagnosis and course. Acta Paediatr Jpn. 1992 Jun;34(3):365–370. doi: 10.1111/j.1442-200x.1992.tb00973.x. [DOI] [PubMed] [Google Scholar]
  25. Kramer L. D., Locke G. E., Byrd S. E., Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology. 1989 May;171(2):459–462. doi: 10.1148/radiology.171.2.2704811. [DOI] [PubMed] [Google Scholar]
  26. Kuenneth C. A., Boyle C., Murphy C. C., Yeargin-Allsopp M. Reproductive risk factors for epilepsy among ten-year-old children in metropolitan Atlanta. Paediatr Perinat Epidemiol. 1996 Apr;10(2):186–196. doi: 10.1111/j.1365-3016.1996.tb00042.x. [DOI] [PubMed] [Google Scholar]
  27. Medina M. T., Rosas E., Rubio-Donnadieu F., Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 1990 Feb;150(2):325–327. [PubMed] [Google Scholar]
  28. Mitchell W. G., Crawford T. O. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics. 1988 Jul;82(1):76–82. [PubMed] [Google Scholar]
  29. Molinari J. L., Soto R., Tato P., Rodriguez D., Retana A., Sepulveda J., Palet A. Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am J Trop Med Hyg. 1993 Oct;49(4):502–512. doi: 10.4269/ajtmh.1993.49.502. [DOI] [PubMed] [Google Scholar]
  30. Monteiro L., Nunes B., Mendonça D., Lopes J. Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients. Acta Neurol Scand. 1995 Jul;92(1):33–40. doi: 10.1111/j.1600-0404.1995.tb00463.x. [DOI] [PubMed] [Google Scholar]
  31. Osuntokun B. O., Adeuja A. O., Nottidge V. A., Bademosi O., Olumide A., Ige O., Yaria F., Bolis C. L., Schoenberg B. S. Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia. 1987 May-Jun;28(3):272–279. doi: 10.1111/j.1528-1157.1987.tb04218.x. [DOI] [PubMed] [Google Scholar]
  32. Pal D. K., Das T., Chaudhury G., Johnson A. L., Neville B. G. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet. 1998 Jan 3;351(9095):19–23. doi: 10.1016/S0140-6736(97)06250-8. [DOI] [PubMed] [Google Scholar]
  33. Pal D. K., Das T., Sengupta S. Comparison of key informant and survey methods for ascertainment of childhood epilepsy in West Bengal, India. Int J Epidemiol. 1998 Aug;27(4):672–676. doi: 10.1093/ije/27.4.672. [DOI] [PubMed] [Google Scholar]
  34. Pal D. K., Nandy S., Sander J. W. Towards a coherent public-health analysis for epilepsy. Lancet. 1999 May 29;353(9167):1817–1818. doi: 10.1016/S0140-6736(99)00189-0. [DOI] [PubMed] [Google Scholar]
  35. Pathak K. M., Gaur S. N. Immunization of pigs with culture antigens of Taenia solium. Vet Parasitol. 1990 Jan;34(4):353–356. doi: 10.1016/0304-4017(90)90081-l. [DOI] [PubMed] [Google Scholar]
  36. Placencia M., Shorvon S. D., Paredes V., Bimos C., Sander J. W., Suarez J., Cascante S. M. Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain. 1992 Jun;115(Pt 3):771–782. doi: 10.1093/brain/115.3.771. [DOI] [PubMed] [Google Scholar]
  37. Rajshekhar V., Chacko G., Haran R. P., Chandy M. J., Chandi S. M. Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation. J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):284–286. doi: 10.1136/jnnp.59.3.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand. 1991 Dec;84(6):465–470. doi: 10.1111/j.1600-0404.1991.tb04996.x. [DOI] [PubMed] [Google Scholar]
  39. Rajshekhar V., Haran R. P., Prakash G. S., Chandy M. J. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J Neurosurg. 1993 Mar;78(3):402–407. doi: 10.3171/jns.1993.78.3.0402. [DOI] [PubMed] [Google Scholar]
  40. Rajshekhar V., Wilson M., Schantz P. M. Cysticercus immunoblot assay in Indian patients with single small enhancing CT lesions. J Neurol Neurosurg Psychiatry. 1991 Jun;54(6):561–562. doi: 10.1136/jnnp.54.6.561-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ramos-Kuri M., Montoya R. M., Padilla A., Govezensky T., Díaz M. L., Sciutto E., Sotelo J., Larralde C. Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol. 1992 Jun;49(6):633–636. doi: 10.1001/archneur.1992.00530300069012. [DOI] [PubMed] [Google Scholar]
  42. Roberts T., Murrell K. D., Marks S. Economic losses caused by foodborne parasitic diseases. Parasitol Today. 1994 Nov;10(11):419–423. doi: 10.1016/0169-4758(94)90171-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rolfs A., Mühlschlegel F., Jansen-Rosseck R., Martins A. R., Bedaque E. A., Tamburus W. M., Pedretti L., Schulte G., Feldmeier H., Kremsner P. Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology. 1995 Mar;45(3 Pt 1):532–538. doi: 10.1212/wnl.45.3.532. [DOI] [PubMed] [Google Scholar]
  44. Rosenfeld E. A., Byrd S. E., Shulman S. T. Neurocysticercosis among children in Chicago. Clin Infect Dis. 1996 Aug;23(2):262–268. doi: 10.1093/clinids/23.2.262. [DOI] [PubMed] [Google Scholar]
  45. Rwiza H. T., Kilonzo G. P., Haule J., Matuja W. B., Mteza I., Mbena P., Kilima P. M., Mwaluko G., Mwang'ombola R., Mwaijande F. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community-based study. Epilepsia. 1992 Nov-Dec;33(6):1051–1056. doi: 10.1111/j.1528-1157.1992.tb01758.x. [DOI] [PubMed] [Google Scholar]
  46. Sander J. W., Shorvon S. D. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):433–443. doi: 10.1136/jnnp.61.5.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sarti E., Schantz P. M., Plancarte A., Wilson M., Gutierrez I. O., Lopez A. S., Roberts J., Flisser A. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg. 1992 Jun;46(6):677–685. doi: 10.4269/ajtmh.1992.46.677. [DOI] [PubMed] [Google Scholar]
  48. Schantz P. M., Sarti E., Plancarte A., Wilson M., Criales J. L., Roberts J., Flisser A. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis. 1994 Jun;18(6):879–885. doi: 10.1093/clinids/18.6.879. [DOI] [PubMed] [Google Scholar]
  49. Senanayake N., Román G. C. Epidemiology of epilepsy in developing countries. Bull World Health Organ. 1993;71(2):247–258. [PMC free article] [PubMed] [Google Scholar]
  50. Shambesh M. K., Craig P. S., Wen H., Rogan M. T., Paolillo E. IgG1 and IgG4 serum antibody responses in asymptomatic and clinically expressed cystic echinococcosis patients. Acta Trop. 1997 Apr 1;64(1-2):53–63. doi: 10.1016/s0001-706x(96)00637-7. [DOI] [PubMed] [Google Scholar]
  51. Singh G. Neurocysticercosos in South-Central America and the Indian subcontinent. A comparative evaluation. Arq Neuropsiquiatr. 1997 Sep;55(3A):349–356. doi: 10.1590/s0004-282x1997000300001. [DOI] [PubMed] [Google Scholar]
  52. Sánchez A. L., Gomez O., Allebeck P., Cosenza H., Ljungström L. Epidemiological study of Taenia solium infections in a rural village in Honduras. Ann Trop Med Parasitol. 1997 Mar;91(2):163–171. doi: 10.1080/00034983.1997.11813126. [DOI] [PubMed] [Google Scholar]
  53. Thussu A., Sehgal S., Sharma M., Lal V., Sawhney I. M., Prabhakar S. Comparison of cellular responses in single- and multiple-lesion neurocysticercosis. Ann Trop Med Parasitol. 1997 Sep;91(6):627–632. doi: 10.1080/00034989760725. [DOI] [PubMed] [Google Scholar]
  54. Tsang V. C., Brand J. A., Boyer A. E. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989 Jan;159(1):50–59. doi: 10.1093/infdis/159.1.50. [DOI] [PubMed] [Google Scholar]
  55. Wadia N., Desai S., Bhatt M. Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. Brain. 1988 Jun;111(Pt 3):597–614. doi: 10.1093/brain/111.3.597. [DOI] [PubMed] [Google Scholar]
  56. Wadia R. S., Makhale C. N., Kelkar A. V., Grant K. B. Focal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1298–1301. doi: 10.1136/jnnp.50.10.1298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Waruiru C. M., Newton C. R., Forster D., New L., Winstanley P., Mwangi I., Marsh V., Winstanley M., Snow R. W., Marsh K. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):152–155. doi: 10.1016/s0035-9203(96)90120-0. [DOI] [PubMed] [Google Scholar]
  58. White A. C., Jr Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis. 1997 Feb;24(2):101–115. doi: 10.1093/clinids/24.2.101. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES